This provider's $11.9M in total Medicare payments ranks in the 99th percentile of Nuclear Medicine providers nationally.
Medicare payments to this provider grew 574% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 29120% in 2022
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $2.2K | $427.49 | 5.12x | $1.8K | $659.2K | 1.5K | 5 |
| 2015 | $1.8K | $383.68 | 4.75x | $1.4K | $440.5K | 1.1K | 3 |
| 2016 | $2.6K | $205.77 | 12.58x | $2.4K | $25.1K | 122 | 3 |
| 2017 | $2.6K | $196.35 | 13.01x | $2.4K | $39.3K | 200 | 3 |
| 2018 | $11.5K | $5.0K | 2.28x | $6.4K | $2.5M | 487 | 5 |
| 2019 | $604.56 | $267.71 | 2.26x | $336.85 | $1.2M | 4.6K | 4 |
| 2020 | $566.67 | $89.97 | 6.30x | $476.70 | $3.8K | 42 | 2 |
| 2021 | $581.25 | $111.71 | 5.20x | $469.54 | $8.9K | 80 | 2 |
| 2022 | $890.79 | $342.17 | 2.60x | $548.62 | $2.6M | 7.6K | 6 |
| 2023 | $514.92 | $204.76 | 2.51x | $310.16 | $4.4M | 21.7K | 5 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| A9607 | Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | 28.8K | $5.9M | $203.37 | 2.47x |
| A9699 | Radiopharmaceutical, therapeutic, not otherwise classified | 2.5K | $4.6M | $1.9K | 2.88x |
| A9513 | Lutetium lu 177, dotatate, therapeutic, 1 millicurie | 4.4K | $1.2M | $277.74 | 2.19x |
| 78802 | Nuclear medicine study of radioactive material distribution at tumor locations in whole body, single day imaging | 180 | $46.4K | $257.87 | 15.51x |
| 79101 | Radioactive drug therapy through a vein | 389 | $45.2K | $116.25 | 17.29x |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | 349 | $44.1K | $126.38 | 5.99x |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | 152 | $25.5K | $167.66 | 4.51x |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis | 396 | $6.7K | $17.01 | 13.00x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 64 | $3.7K | $58.43 | 7.53x |
| 77263 | Complex radiation therapy planning | 26 | $3.6K | $137.08 | 32.83x |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 35 | $3.0K | $84.85 | 8.84x |
| 77370 | Special medical radiation therapy consultation | 26 | $2.8K | $107.83 | 4.64x |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | 28 | $2.8K | $98.94 | 4.55x |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | 22 | $2.6K | $116.60 | 6.43x |
| 96374 | Injection of drug or substance into a vein for therapy, diagnosis, or prevention | 67 | $2.4K | $35.42 | 3.09x |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | 32 | $1.4K | $43.17 | 8.11x |
| J1940 | Injection, furosemide, up to 20 mg | 82 | $37.51 | $0.46 | 389.76x |
This provider submits charges 2.74 times higher than what Medicare actually pays.
A markup ratio of 2.74x means for every $100 Medicare pays, this provider initially charges $274. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data